Resident Handbook - UC Davis Health System

MANAGEMENT OF SIGNIFICANTLY ELEVATED INR WITH OR WITHOUT BLEEDING 4INR 5.0 to 8.9, no significant bleeding: Omit 1 to 2 doses; reduce dose 10 to 20 percent; monitor frequently. Alternately consider vitamin K2.5 mg orally.INR ≥ 9.0, no significant bleeding: Hold warfarin therapy; give vitamin K 5 mg orally; monitor frequently. Resume at lower dose whenINR is therapeutic.Serious bleeding, any INR:Hold warfarin; refer patient to the Emergency DepartmentANTICOAGULATION PATIENT EDUCATIONYour provider has prescribed an Anticoagulant Medication. The name of the medication is:(provider to circle the medication prescribed)Warfarin (Coumadin): an oral tabletEnoxaparin (Lovenox): a small injection into the skinBenefits:Anticoagulant therapy is used to make your blood “thinner” than normal to treat or preventcomplications of a disease. “Thinning” the blood dissolves or prevents clots from forming andblocking blood vessels. This decreases the chance of stroke, heart attack and other problemsfrom blocked vessels including in the lungs, brain and legs.Risks:Potential complications and side effects of anticoagulant therapy include:Bruising of the skinIrritation at the site of injection (Enoxaparin)Page 129 of 153C:\Documents and Settings\dhutak\Desktop\rshb13.doc